Normal Saline for Parenteral Use Market

Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.
Normal Saline for Parenteral Use Market studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection
Normal Saline for Parenteral Use Market contains market size and forecasts of Normal Saline for Parenteral Use in global, including the following market information:
Global Normal Saline for Parenteral Use Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Normal Saline for Parenteral Use Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five Normal Saline for Parenteral Use companies in 2021 (%)
The global Normal Saline for Parenteral Use market was valued at 3225.9 million in 2021 and is projected to reach US$ 3984.3 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Flexible Bag Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Normal Saline for Parenteral Use include Baxter, Pfizer, B. Braun, ICU Medical, Fresenius Kabi, Otsuka, Kelun Group, CR Double-Cran and SSY Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Normal Saline for Parenteral Use manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Normal Saline for Parenteral Use Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Normal Saline for Parenteral Use Market Segment Percentages, by Type, 2021 (%)
Flexible Bag
Plastic Bottles
Glass Bottles
Global Normal Saline for Parenteral Use Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Normal Saline for Parenteral Use Market Segment Percentages, by Application, 2021 (%)
Intramuscular Injection
Intravenous Injection
Others
Global Normal Saline for Parenteral Use Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Normal Saline for Parenteral Use Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Normal Saline for Parenteral Use revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Normal Saline for Parenteral Use revenues share in global market, 2021 (%)
Key companies Normal Saline for Parenteral Use sales in global market, 2017-2022 (Estimated), (M Units)
Key companies Normal Saline for Parenteral Use sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
Pfizer
B. Braun
ICU Medical
Fresenius Kabi
Otsuka
Kelun Group
CR Double-Cran
SSY Group
Cisen Pharmaceutical
Denis Chem Lab Limited
Shree Krishnakeshav Laboratories
Pharmally International